Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

A clinical study of MK-2420 in healthy people (MK-2420-002)

This research study, called MK-2420-002, is looking at a new medicine called MK-2420. It's a very early-stage study, specifically designed for healthy adults aged 18 and over, both men and women. The main goal is to see how the medicine behaves inside the human body and to check for any early signs of side effects. This kind of research is essential for developing new treatments, like those for conditions such as rheumatoid arthritis. By understanding the medicine's basic effects in healthy people first, scientists can decide if it's safe and promising enough to be tested later in people who actually have the condition. Your involvement would help researchers learn crucial information to potentially help future patients.

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Merck Sharp & Dohme LLC

Enrolment target

Start

27 Feb 2025

Rheumatoid arthritis

What is this study about?

This study is a medical research project focused on a new medicine called MK-2420. When a new medicine is developed, it goes through several stages of testing. This particular study is in one of the very first stages, often called 'Phase I' or 'Human Pharmacology'. This means that the main purpose is to carefully check how the medicine works in the human body, how it's absorbed, distributed, processed, and removed. It's also a critical step to see if there are any immediate or unexpected side effects in healthy individuals before it's given to people who are unwell.

The researchers are studying MK-2420 because it has the potential to help people with rheumatoid arthritis in the future. Rheumatoid arthritis is a long-term condition that causes pain, swelling, and stiffness in the joints. However, this specific study is not treating rheumatoid arthritis; instead, its goal is to gather basic, fundamental information about MK-2420 itself. Think of it like testing a car engine in a controlled environment before putting it in a car and driving it on the road.

By taking part, you would be helping medical science advance. The information gained from healthy volunteers in studies like this is really important. It helps scientists decide if a new medicine is safe enough and behaves predictably enough in the body to move on to the next stages of testing, where it would then be given to people with rheumatoid arthritis to see if it helps their symptoms. Your contribution would directly help in the journey of potentially developing new and better treatments.

Key takeaways

This is an early-stage study testing a new medicine called MK-2420.
It's for healthy adults aged 18 and over, both men and women.
The main goal is to understand how the medicine works in the body and check for safety.
The medicine may eventually help people with rheumatoid arthritis, but this study isn't treating that condition.
Your participation could help advance medical science.
You can withdraw from the study at any time.

Who may be eligible?

To join this study, you need to be a healthy adult. This means you should generally be in good health and not have any serious medical conditions.

Anyone aged 18 or older can be considered for this study, male or female. There's no upper age limit mentioned, but you'll need to be fit and healthy enough to take part as decided by the study doctors.

Before you can join, the study team will carry out some health checks to make sure the study is a safe and suitable option for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Are you generally in good health?
Are you able to attend clinic visits as required?
Do you understand what taking part in a research study involves?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would first have a screening visit. During this visit, doctors and nurses would perform various health checks, such as blood tests, a physical exam, and check your medical history, to make sure you are healthy and meet all the study requirements.

If you qualify, you would receive the new medicine, MK-2420, which is likely given in a specific way, such as by mouth or injection, depending on the medicine. You would have regular visits to the clinic or hospital, during which the study team would monitor your health carefully, take more blood samples, and ask about any new symptoms or side effects you might be experiencing.

The exact number of visits, how long each visit lasts, and the total duration you'd be involved in the study would be explained in detail by the study team. They will also tell you if you need to stay overnight at the clinic for any part of the study. Your commitment would be essential for collecting all the necessary information.

Potential risks and benefits

Potential benefits of taking part include helping advance medical science, which could lead to new treatments for conditions like rheumatoid arthritis in the future. You'd also receive comprehensive medical check-ups throughout the study. However, as with any new medicine, there are potential risks, including side effects that are currently unknown. The study team will explain all known and potential risks in detail. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Belgium

Common questions

What is MK-2420?

MK-2420 is a new medicine that is being investigated to understand how it works in the human body. It could potentially be used for conditions like rheumatoid arthritis in the future.

Why are you testing it on healthy people?

Testing on healthy people in the early stages helps researchers understand how the medicine behaves in the body and if it causes any immediate side effects, before trying it on people who are unwell.

Will I get rheumatoid arthritis from this study?

No, this study is about understanding the medicine's effects, not about giving participants the condition. You will be carefully monitored throughout the study.

Will I be paid to take part?

While the study information doesn't specify payment, it's common for studies like this to provide some compensation for your time and travel. This is a good question to ask the study team.

What if I feel unwell during the study?

You will be closely monitored by doctors and nurses. If you feel unwell at any point, it's very important to tell the study team immediately so they can provide care and support.